Pfizer- Global Medical Grants – Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung Cancer- Full Application

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire with Unit

Memorial Deadline: Friday 16th, September 2022

External Deadline: Wednesday 21st, September 2022


By Invitation only – Must have submitted the Request for Proposal


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Link: Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung Cancer


Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: August 9, 2022